Drugmaker Aegerion’s Chapter 11 plan confirmed in New York
Bankrupt US drugmaker Aegerion’s Chapter 11 plan, which envisages it sold to European rival Amryt Pharma, has been confirmed by a New York bankruptcy court.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10